BRIEF-Lundbeck, Otsuka launches schizophrenia drug in Europe

COPENHAGEN, March 17 Mon Mar 17, 2014 4:05am EDT

Related Topics

COPENHAGEN, March 17 (Reuters) - Danish pharmaceutical company H Lundbeck A/S said on Monday: * Schizophrenia drug Abilify Maintena is now available in a number of European countries * Denmark is the first European country where Abilify Maintena is fully reimbursed * More than ten markets are expected to launch Abilify Maintena by the end of 2014

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article